Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Acurx Pharmaceuticals, Inc. (ACXP)

3.63   -0.17 (-4.47%) 06-29 18:10
Open: 3.85 Pre. Close: 3.8
High: 3.91 Low: 3.62
Volume: 30,568 Market Cap: 37(M)
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.91 - 3.93 3.93 - 3.95
Low: 3.58 - 3.6 3.6 - 3.61
Close: 3.6 - 3.63 3.63 - 3.66

Technical analysis

as of: 2022-06-29 4:51:12 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 4.67     One year: 5.45
Support: Support1: 2.98    Support2: 2.35
Resistance: Resistance1: 4    Resistance2: 4.67
Pivot: 3.65
Moving Average: MA(5): 3.67     MA(20): 3.4
MA(100): 3.5     MA(250): 4.28
MACD: MACD(12,26): 0.1     Signal(9): 0.1
Stochastic oscillator: %K(14,3): 77.1     %D(3): 77.5
RSI: RSI(14): 58.9
52-week: High: 6.34  Low: 2.32
Average Vol(K): 3-Month: 16 (K)  10-Days: 9 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ACXP ] has closed above bottom band by 46.6%. Bollinger Bands are 28.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 29 Jun 2022
Stock Alert: Acurx (ACXP) Down 7.90% in Pre-Market Move for June 29 - Equities News

Wed, 22 Jun 2022
Acurx Pharmaceuticals (NASDAQ:ACXP) Stock Price Down 0.3% - Defense World

Thu, 17 Mar 2022
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update - PR Newswire

Wed, 23 Feb 2022
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Announce Publication of Ibezapolstat Phase 2a Clinical Study Results In Clinical Infectious Disease - BP Journal

Mon, 31 Jan 2022
Top Stocks to Buy Now? 3 Biotech Stocks for your Watchlist | BioPub - Midas Letter

Thu, 30 Sep 2021
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021 - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 10 (M)
Shares Float 8 (M)
% Held by Insiders 23.3 (%)
% Held by Institutions 3.1 (%)
Shares Short 49 (K)
Shares Short P.Month 87 (K)

Stock Financials

EPS -1.49
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.03
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -122.5
Return on Equity (ttm) -211.9
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -6 (M)
Levered Free Cash Flow -2 (M)

Stock Valuations

PE Ratio -2.45
PEG Ratio 0
Price to Book value 3.49
Price to Sales 0
Price to Cash Flow -5.88

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.